In terms of working capital, AstraZeneca PLC maintains a healthy position.
The total current assets of the company are valued at $25054000000.
This represents a growth rate of 10.893% compared to the previous year.
Breaking down the current assets, the cash and investments are worth $5840000000, exhibiting a growth rate of -5.287% year-on-year.
The receivables, another significant portion of the current assets, are valued at $13552000000.
The year-on-year growth rate for receivables is 36.572%.
The inventory, which forms a critical part of the assets, is valued at $5424000000.
This represents a healthy year-on-year growth of 15.429%
On the liabilities side, the company's current liabilities total $30542000000.
This reflects a growth rate of 16.160% over the previous year, indicating the company's financial obligations are well under control.
2023
2022
2021
2020
2019
2018
Cash and investments
5840.00
6166.00
6329.00
7832.00
5369.00
4831.00
Receavebles
13552.00
9923.00
10758.00
5651.00
5181.00
86
Inventory
5424.00
4699.00
8983.00
4024.00
3193.00
2890.00
Other
116.00
11489.00
105.00
1877.00
971.00
7107.00
Total Current Assets
25054.00
22593.00
26244.00
19544.00
15563.00
15591.00
Acc Payable
3267.00
19040.00
18938.00
15785.00
13987.00
12841.00
Short Term Debt
5400.00
5542.00
1893.00
2386.00
2010.00
1754.00
Other Current Liab
21726.00
1530.00
748.00
508.00
2092.00
12818.00
Current Liabilities
30542.00
26293.00
22594.00
20307.00
18117.00
16292.00
Capital Structure
When examining the capital structure of AstraZeneca PLC, it is clear that the company manages a robust portfolio.
The value of their total assets clocks in at $101119000000.
When juxtaposed with the previous year, this marks a growth rate of 4.805%, showcasing the company's ability to steadily grow its asset base.
Turning to liabilities, the company has total liabilities amounting to $61953000000.
Compared to the prior year, this reflects a growth rate of 4.254%.
The long-term debt forms a sizable part of these liabilities, coming in at $23222000000.
Over the last year, the long-term debt has grown by -1.976%.
On the asset side, the cash and equivalent reserves are worth $5840000000.
The year-on-year growth of these reserves is -5.287%.
The company's common stock, another important asset, holds a value of $388000000, growing at a rate of 0.258% from the previous year.
Finally, the company's retained earnings stand at $1502000000, marking a growth rate of -361.672% year-over-year.
These earnings represent the profits that AstraZeneca PLC has chosen to reinvest in the business rather than distribute as dividends.
Total Assets
$101,119.00
Total liabilities
$61,953,000,000.00
Long term debt
$23,222.00
Cash and eqv
$5,840,000,000.00
Goodwill
$20,048.00
Retained earnings
$1,502,000,000.00
Common stock
$349.09
Enterprise Value
$16.77
Historical dividend key summary
AstraZeneca PLC's dividend per share is $1.45, showing the earnings shared with shareholders per share. It has grown by -32.069% this year, suggesting that the company is generating increased income for shareholders and expecting future earnings growth.
Years
Q1
Q2
Q3
Q4
Total
2024
0.985
0.000
0.000
0.000
0.985
2023
0.985
0.000
0.465
0.000
1.450
2022
0.985
0.000
0.465
0.000
1.450
2021
0.950
0.000
0.450
0.000
1.400
2020
0.950
0.000
0.450
0.000
1.400
2019
0.950
0.000
0.450
0.000
1.400
2018
0.950
0.000
0.450
0.000
1.400
2017
0.950
0.000
0.450
0.000
1.400
2016
0.950
0.000
0.450
0.000
1.400
2015
0.950
0.000
0.450
0.000
1.400
2014
0.950
0.000
0.450
0.000
1.400
2013
0.950
0.000
0.450
0.000
1.400
2012
0.975
0.000
0.450
0.000
1.425
2011
0.925
0.000
0.425
0.000
1.350
2010
0.855
0.000
0.350
0.000
1.205
2009
0.750
0.000
0.295
0.000
1.045
2008
0.675
0.000
0.275
0.000
0.950
2007
0.615
0.000
0.260
0.000
0.875
2006
0.460
0.000
0.245
0.000
0.705
2005
0.323
0.000
0.190
0.000
0.512
2004
0.270
0.000
0.147
0.000
0.417
2003
0.261
0.000
0.128
0.000
0.389
2002
0.261
0.000
0.128
0.000
0.389
2001
0.261
0.000
0.128
0.000
0.389
2000
0.261
0.000
0.128
0.536
0.925
1999
0.000
0.175
0.128
0.000
0.303
1998
0.256
0.000
0.141
0.000
0.398
1997
0.224
0.000
0.133
0.000
0.357
1996
0.127
0.000
0.120
0.000
0.247
1995
0.175
0.000
0.112
0.000
0.287
1994
0.157
0.000
0.103
0.000
0.260
1993
0.000
0.000
0.097
0.000
0.097
Net earnings per share (EPS)
AstraZeneca PLC has an EPS of $1.93, which signifies the profit allocated per share of common stock. With a growth rate of 82.075% this year, it indicates the company's increasing profitability and potential for share value growth. This trend signals robust financial performance and future potential.
Years
Q1
Q2
Q3
Q4
Total
2023
0.58
0.59
0.45
0.31
1.93
2022
0.12
0.12
0.53
0.29
1.06
2021
0.6
0.21
-0.55
-0.11
0.15
2020
0.3
0.29
0.25
0.39
1.23
2019
0.24
0.045
0.12
0.12
0.52
2018
0.14
0.14
0.17
0.41
0.86
2017
0.21
0.19
0.27
0.52
1.19
2016
0.26
-0.0012
0.4
0.73
1.39
2015
0.22
0.28
0.31
0.32
1.13
2014
0.2
0.32
0.1
-0.13
0.49
2013
0.41
0.33
0.5
-0.21
1.03
2012
0.64
0.63
0.61
0.61
2.49
2011
1.04
0.77
1.28
0.58
3.67
2010
0.96
0.73
0.54
0.58
2.81
2009
0.74
0.59
0.73
0.53
2.59
2008
0.52
0.56
0.6
0.43
2.11
2007
0.51
0.49
0.46
0.43
1.89
2006
0.45
0.52
0.52
0.47
1.96
2005
31.5
0.39
0.39
0.39
32.67
2004
23.5
0.24
0.34
0.24
24.32
2003
0.27
0.2
0.24
0.19
0.90
2002
0.28
0.23
0.19
0.22
0.92
2001
0.22
0.2
0.21
0.56
1.19
2000
0.19
0.19
0.18
0.16
0.72
1999
0.12
0.12
0.14
-0.0489
0.33
1998
0.2
0.21
0.13
0.11
0.65
1997
0.2
0.2
0.47
0.17
1.04
1996
0.17
0.17
0.13
0.33
0.80
1995
0.14
0.14
0.12
0.063
0.46
1994
0.065
0.13
0.11
0.17
0.47
1993
0.13
0.13
0.065
0.065
0.40
Brief information
AstraZeneca PLC (AZN) stock split history
Understanding the historical stock splits of AstraZeneca PLC (AZN) provides insights into its past financial decisions and investor sentiment. A stock split occurs when a company increases its share count by dividing its existing shares. The most recent split took place on July 27, 2015 with a ratio of 2:1. Throughout its history, the company has undergone 2 stock splits. Below, we delve deeper into this history, highlighting past financial strategies.
